Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T49898 | Target Info | |||
Target Name | Cyclin-dependent kinase 1 (CDK1) | ||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | CDK1 | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | AZD-5438 | Ligand Info | |||
Canonical SMILES | CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C | ||||
InChI | 1S/C18H21N5O2S/c1-12(2)23-13(3)20-11-17(23)16-9-10-19-18(22-16)21-14-5-7-15(8-6-14)26(4,24)25/h5-12H,1-4H3,(H,19,21,22) | ||||
InChIKey | WJRRGYBTGDJBFX-UHFFFAOYSA-N | ||||
PubChem Compound ID | 16747683 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6GU3 CDK1/CyclinB/Cks2 in complex with AZD5438 | ||||||
Method | X-ray diffraction | Resolution | 2.65 Å | Mutation | Yes | [1] |
PDB Sequence |
LGSMEDYTKI
7 EKIGEGTYGV17 VYKGRHKTTG27 QVVAMKKIRL37 ESEEEGVPST47 AIREISLLKE 57 LRHPNIVSLQ67 DVLMQDSRLY77 LIFEFLSMDL87 KKYLDSIPPG97 QYMDSSLVKS 107 YLYQILQGIV117 FCHSRRVLHR127 DLKPQNLLID137 DKGTIKLADF147 GLARAFGIPI 157 RVYTHEVVTL167 WYRSPEVLLG177 SARYSTPVDI187 WSIGTIFAEL197 ATKKPLFHGD 207 SEIDQLFRIF217 RALGTPNNEV227 WPEVESLQDY237 KNTFPKWKPG247 SLASHVKNLD 257 ENGLDLLSKM267 LIYDPAKRIS277 GKMALNHPYF287 ND
|
|||||
|
||||||
PDB ID: 6GU7 CDK1/Cks2 in complex with AZD5438 | ||||||
Method | X-ray diffraction | Resolution | 2.75 Å | Mutation | No | [1] |
PDB Sequence |
MEDYTKIEKI
10 GEGTYGVVYK20 GRHKTTGQVV30 AMKKIRLESE40 EEGVPSTAIR50 EISLLKELRH 60 PNIVSLQDVL70 MQDSRLYLIF80 EFLSMDLKKY90 LDSIPPGQYM100 DSSLVKSYLY 110 QILQGIVFCH120 SRRVLHRDLK130 PQNLLIDDKG140 TIKLADFGLA150 RAFGIVTLWY 169 RSPEVLLGSA179 RYSTPVDIWS189 IGTIFAELAT199 KKPLFHGDSE209 IDQLFRIFRA 219 LGTPNNEVWP229 EVESLQDYKN239 TFPKWKPGSL249 ASHVKNLDEN259 GLDLLSKMLI 269 YDPAKRISGK279 MALNHPYFND289 LDNQ
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition. Cell Chem Biol. 2019 Jan 17;26(1):121-130.e5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.